RGCNasdaqMedicinal Chemicals & Botanical Products
Regencell Bioscience Holdings Ltd
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 7, 2026
$10.05+0.46 (+4.80%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Regencell Bioscience's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Yat-Gai Au | 437,896,116 | 88.60% | 13D (active) amendment | Jul 11, 2025 |
| Regencell (BVI) Limited | 11,221,821 | 86.20% | 13D (active) amendment | Mar 10, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Yat-Gai Au | Chief Executive Officer, Director, 10% owner | 437,896,116 | 88.56% | Mar 18, 2026 |
| James Wai Hong Chung | COO and Chief Strategy Officer, Director | – | – | Mar 18, 2026 |
| Ho Yau Chan | Financial Controller | – | – | Mar 18, 2026 |
| Yat-Pui Au | Chief Business Officer | 581,514 | 0.12% | Mar 18, 2026 |
| William Wing Yan Dr Lo | Director | – | – | May 29, 2026 |
| Evana Yee Wah Hui | Director | – | – | May 29, 2026 |
| Margaret Hoor Han Lo | Director | 604,050 | 0.12% | Mar 18, 2026 |